Multiomic evidence of coordinated complex rearrangements, enhancer hijacking, and epigenomic signatures in the first whole-chromosome-phased myeloma genomes

N Nathan Becker (1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States) E Enze Liu Z Zackary Sanborn (3Dovetail Genomics, Part of Cantata Bio LLS, Scotts Valley, United States) A Attaya Suvannasankha (7Indiana University School of Medicine, Indianapolis, United States) K Kelvin Lee (2Indiana Universirty, Department of Immunology, Indianapolis, United States) D Dickran Kazandjian J James Hoffman (1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States) B Benjamin Diamond (University of Miami) A Abhishek Pandey (Center for Infectious Disease Modeling and Analysis, Yale School of Public Health) R Rafat Abonour (2Division of Hematology Oncology, Indiana University, Indianapolis, United States) O Ola Landgren L Lisa Munding (3Dovetail Genomics, Part of Cantata Bio LLS, Scotts Valley, United States) A Aneta Mikulasova (4Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom) B Brian Walker (1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States)

Abstract

Abstract Introduction Genomic analysis of multiple myeloma has advanced greatly in recent years, but traditional short-read sequencing has limited the power to examine complex or linked events across the genome. Linking markers together into large phase-blocks, and examining the interaction of different sequencing modalities, allows complex genomic and epigenomic states to be integrated to generate true multiomic haplotypes at the chromosomal level. Methods Fourteen multiple myeloma patient-derived xenografts were used to generate multiomic data including short- (Illumina) and long-read (PacBio) whole genome sequencing (WGS, average depths 92x and 16x) to identify single nucleotide variations (SNVs), copy number (CN) abnormalities, structural variation (SV), and DNA methylation, as well as expression (>124 million reads), chromatin states (Cut&Tag-IT, >10M reads, H3K27ac, H3K4me1, H3K4me3, H3K9me3, H3K27me3, and H3K36me3), and Micro-C/LinkPrep (Dovetail Genomics; >900M reads) and HiChIP (Dovetail, H3K27ac mark) to identify 3D chromatin architecture/folding and enhancer-target gene interactions. Micro-C/LinkPrep interaction reads were also used for chromosome-scale haplotype phasing, onto which SNVs, SVs, CNVs, DNA methylation, expression, and chromatin marks were super-imposed based on heterozygous SNPs. Data integration resulted in haplotype-phased somatic events for genomic architecture, SNVs, SVs, epigenomic states, and expression markers. Results For the first time, complete haplotype-resolved assemblies at the chromosomal level have been generated in multiple myeloma. A 100x coverage genome Micro-C/LinkPrep libraries we were able to phase the long and short arms of each chromosome, resulting in an average 96.3% haplotype phasing per autosome – thereby generating chromosome length haplotypes up to 241.9 Mb in length. In comparison, HiFi long-read (15 kb reads) WGS (PacBio) was able to generate phase-blocks of up to 4.6 Mb (median 44.1 kb). We examined the prevalence of somatic mutations on each haplotype across all chromosomes to determine if one parental haplotype was more likely to be mutated than the other. In one sample, of 19,306 mutations 56% were phased to their respective haplotypes and were generally equally distributed across both haplotypes. Haplotype-specific interaction heatmaps were generated allowing us to examine the interaction of complex SVs across chromosomes. In one sample, we identified a primary t(11;14) and additional SV events linked to the t(11;14) including a t(3;14), t(11;17), and t(3;17) which created a cyclical pattern. Using the chromosome-scale haplotype maps we were able to determine the proportion of interacting reads for the four possible haplotype combinations between any two chromosomes. We found that 70-83.5% of reads support specific combinations of haplotype interactions, and that all four SV events were linked and involved the same haplotypes on each chromosome. The pattern of interactions combined with breakpoint analysis in this case indicated a four-way complex reciprocal translocation between chromosomes 3,11,14 and 17. Integration of epigenetic data in this complex SV, including DNA methylation (HiFi reads) and super-enhancer histone marks (CUT&Tag-IT), showed DNA hyper-methylation 17 kb upstream of CCND1 next to the t(11;14) breakpoint as well as increased H3K27ac marks on the same haplotype, indicating spreading of the activating broad domain from the IGH super-enhancer on chromosome 14. Equally, the hypomethylated DNA marks at the IGH promoter are spread to chromosome 3, via the t(3;14), resulting in over-expression of the proto-oncogene SKIL. The same is true for the t(3;17), which shows hypomethylation on both sides of the breakpoint, compared to the non-translocated allele. Overall, this exemplifies the underlying intricacy and impact of complex SVs across multiple linked chromosomes and their epigenetic states. Conclusion We have generated the first chromosome scale haplotype-resolved genomes in multiple myeloma and integrated them with epigenetic states. We have shown that it is possible to identify interactions across chromosomes to resolve complex SVs as well as their epigenomic consequences to understand the intricate nature of how the genome is organized.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue Supplement 1
Published November 03, 2025
Pages 3928-3928
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (14)

N

Nathan Becker

1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States

E

Enze Liu

Z

Zackary Sanborn

3Dovetail Genomics, Part of Cantata Bio LLS, Scotts Valley, United States

A

Attaya Suvannasankha

7Indiana University School of Medicine, Indianapolis, United States

K

Kelvin Lee

2Indiana Universirty, Department of Immunology, Indianapolis, United States

D

Dickran Kazandjian

J

James Hoffman

1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States

B

Benjamin Diamond

University of Miami

A

Abhishek Pandey

Center for Infectious Disease Modeling and Analysis, Yale School of Public Health

R

Rafat Abonour

2Division of Hematology Oncology, Indiana University, Indianapolis, United States

O

Ola Landgren

L

Lisa Munding

3Dovetail Genomics, Part of Cantata Bio LLS, Scotts Valley, United States

A

Aneta Mikulasova

4Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom

B

Brian Walker

1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States